J. Mark Ruscin

1.3k total citations
23 papers, 1.0k citations indexed

About

J. Mark Ruscin is a scholar working on Epidemiology, Geriatrics and Gerontology and Pharmacology. According to data from OpenAlex, J. Mark Ruscin has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Geriatrics and Gerontology and 4 papers in Pharmacology. Recurrent topics in J. Mark Ruscin's work include Pharmaceutical Practices and Patient Outcomes (4 papers), Emergency and Acute Care Studies (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). J. Mark Ruscin is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (4 papers), Emergency and Acute Care Studies (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). J. Mark Ruscin collaborates with scholars based in United States. J. Mark Ruscin's co-authors include Robert L. Page, Robert J. Valuck, Jacquelyn Bainbridge, Todd P. Semla, Sunny A. Linnebur, Nora Morgenstern, Andreas Brieke, Evelyn Hutt, Tiffany A. Radcliff and Daniel W. Barry and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Epidemiology and Journal of the American Geriatrics Society.

In The Last Decade

J. Mark Ruscin

22 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Mark Ruscin United States 16 227 163 155 151 126 23 1.0k
T. S. Dharmarajan United States 19 126 0.6× 112 0.7× 96 0.6× 271 1.8× 106 0.8× 77 1.1k
Scott Martin Vouri United States 16 226 1.0× 179 1.1× 103 0.7× 97 0.6× 16 0.1× 87 977
Philippe Chassagne France 18 158 0.7× 164 1.0× 76 0.5× 361 2.4× 129 1.0× 75 1.2k
Susan Ogle Australia 15 305 1.3× 107 0.7× 119 0.8× 82 0.5× 30 0.2× 27 1.0k
Adele L Towers United States 10 142 0.6× 111 0.7× 67 0.4× 174 1.2× 174 1.4× 15 831
Patrick D. Meek United States 13 646 2.8× 64 0.4× 152 1.0× 137 0.9× 108 0.9× 30 1.2k
Silvia Bustacchini Italy 19 412 1.8× 119 0.7× 123 0.8× 92 0.6× 24 0.2× 42 1.2k
Madlen Gazarian Australia 18 114 0.5× 54 0.3× 143 0.9× 152 1.0× 62 0.5× 41 968
Ulrich Thiem Germany 20 429 1.9× 434 2.7× 254 1.6× 179 1.2× 18 0.1× 64 1.8k
Ovidio Brignoli Italy 18 199 0.9× 101 0.6× 95 0.6× 112 0.7× 9 0.1× 52 1.4k

Countries citing papers authored by J. Mark Ruscin

Since Specialization
Citations

This map shows the geographic impact of J. Mark Ruscin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mark Ruscin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mark Ruscin more than expected).

Fields of papers citing papers by J. Mark Ruscin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mark Ruscin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mark Ruscin. The network helps show where J. Mark Ruscin may publish in the future.

Co-authorship network of co-authors of J. Mark Ruscin

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mark Ruscin. A scholar is included among the top collaborators of J. Mark Ruscin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mark Ruscin. J. Mark Ruscin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hildreth, Kerry L., Daniel W. Barry, Kerrie L. Moreau, et al.. (2013). Effects of Testosterone and Progressive Resistance Exercise in Healthy, Highly Functioning Older Men With Low-Normal Testosterone Levels. The Journal of Clinical Endocrinology & Metabolism. 98(5). 1891–1900. 117 indexed citations
2.
Linnebur, Sunny A., Douglas N. Fish, J. Mark Ruscin, et al.. (2011). Impact of a Multidisciplinary Intervention on Antibiotic Use for Nursing Home–Acquired Pneumonia. ˜The œAmerican journal of geriatric pharmacotherapy. 9(6). 442–450.e1. 37 indexed citations
3.
Haverhals, Leah, et al.. (2011). Older Adults with Multi-Morbidity: Medication Management Processes and Design Implications for Personal Health Applications. Journal of Medical Internet Research. 13(2). e44–e44. 48 indexed citations
4.
Hutt, Evelyn, J. Mark Ruscin, Sunny A. Linnebur, et al.. (2010). A Multifaceted Intervention to Implement Guidelines Did Not Affect Hospitalization Rates for Nursing Home–Acquired Pneumonia. Journal of the American Medical Directors Association. 12(7). 499–507. 18 indexed citations
5.
Hutt, Evelyn, Tiffany A. Radcliff, Kathleen S. Oman, et al.. (2010). Impact of NHAP Guideline Implementation Intervention on Staff and Resident Vaccination Rates. Journal of the American Medical Directors Association. 11(5). 365–370. 14 indexed citations
6.
Bainbridge, Jacquelyn & J. Mark Ruscin. (2009). Challenges of Treatment Adherence in Older Patients with Parkinson’s Disease. Drugs & Aging. 26(2). 145–155. 59 indexed citations
7.
Page, Robert L., J. Mark Ruscin, Jacquelyn Bainbridge, & Andreas Brieke. (2008). Restless Legs Syndrome Induced by Escitalopram: Case Report and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(2). 271–280. 44 indexed citations
8.
Bainbridge, Jacquelyn, Robert L. Page, & J. Mark Ruscin. (2008). Elucidating the Mechanism of Action and Potential Interactions of MAO-B Inhibitors. Neurologic Clinics. 26(3). 85–96. 13 indexed citations
9.
Griend, Joseph P. Vande, Sunny A. Linnebur, J. Mark Ruscin, et al.. (2008). Vitamin D intervention by pharmacists in geriatric outpatients. Journal of the American Pharmacists Association. 48(4). 501–509a. 2 indexed citations
10.
Linnebur, Sunny A., Sheryl F. Vondracek, Joseph P. Vande Griend, J. Mark Ruscin, & Michael T. McDermott. (2007). Prevalence of vitamin D insufficiency in elderly ambulatory outpatients in Denver, Colorado. ˜The œAmerican journal of geriatric pharmacotherapy. 5(1). 1–8. 38 indexed citations
11.
Page, Robert L. & J. Mark Ruscin. (2006). The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. ˜The œAmerican journal of geriatric pharmacotherapy. 4(4). 297–305. 133 indexed citations
12.
Ruscin, J. Mark, Robert L. Page, & John C. Scott. (2006). Hydrochlorothiazide-induced angioedema in a patient allergic to sulfonamide antibiotics: Evidence from a case report and a review of the literature. ˜The œAmerican journal of geriatric pharmacotherapy. 4(4). 325–329. 15 indexed citations
13.
Hutt, Evelyn, J. Mark Ruscin, Kitty Corbett, et al.. (2006). A Multifaceted Intervention to Implement Guidelines Improved Treatment of Nursing Home–Acquired Pneumonia in a State Veterans Home. Journal of the American Geriatrics Society. 54(11). 1694–1700. 41 indexed citations
14.
Ruscin, J. Mark, et al.. (2005). Tumor Necrosis Factor‐α and Involuntary Weight Loss in Elderly, Community‐Dwelling Adults. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(3). 313–319. 11 indexed citations
15.
Linnebur, Sunny A. & J. Mark Ruscin. (2005). Cholinesterase inhibitor use in geriatric outpatients with dementia. American Journal of Health-System Pharmacy. 62(9). 923–926. 6 indexed citations
16.
Valuck, Robert J. & J. Mark Ruscin. (2004). A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. Journal of Clinical Epidemiology. 57(4). 422–428. 185 indexed citations
17.
Page, Robert L., Wendolyn S. Gozansky, & J. Mark Ruscin. (2003). Possible Heart Failure Exacerbation Associated with Rosiglitazone: Case Report and Literature Review. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(7). 945–954. 25 indexed citations
18.
Page, Robert L., et al.. (2001). Possible Interaction Between Intravenous Azithromycin and Oral Cyclosporine. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(11). 1436–1443. 27 indexed citations
19.
Ruscin, J. Mark & Nora Morgenstern. (1999). Tolterodine Use for Symptoms of Overactive Bladder. Annals of Pharmacotherapy. 33(10). 1073–1082. 24 indexed citations
20.
Ruscin, J. Mark & Todd P. Semla. (1996). Assessment of Medication Management Skills in Older Outpatients. Annals of Pharmacotherapy. 30(10). 1083–1088. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026